ArticleFolia microbiologica2026
Antifungal activity of biosynthesized copper oxide nanoparticles (CuONPs) against three different formae speciales of Fusarium oxysporum.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium oxysporum is a major pathogen of economically important crops, including strawberries, blackberries, tomatoes, and many others. Conventional fungicides are often ineffective, and their excessive use poses risks to health and the environment. As an alternative, copper oxide nanoparticles (CuONPs) synthesized through eco-friendly methods have shown promising antifungal activity. To identify the optimal reducing agent for nanoparticle synthesis, this study evaluated supernatants from Trichoderma harzianum cultured at different temperatures against F. oxysporum. The supernatant obtained at 30 °C exhibited the highest intrinsic inhibitory activity (15.5%), followed by 33 °C (11.6%) and 25 °C (5%). The extract produced at 30 °C was selected and used for CuONPs biosynthesis to obtain a synergistic effect. CuONPs formation was confirmed by a UV-vis absorption peak at 290 nm. Dynamic light scattering analysis revealed a hydrodynamic diameter of 743.9 ± 150.2 nm, a Zeta potential of - 31 ± 4.48 mV, and a polydispersity index of 0.544. Using an automated machine-learning segmentation approach, transmission electron microscopy combined with machine-learning segmentation, showed nanoparticles with a mean Feret diameter of 2.73 ± 0.90 nm and were predominantly quasi-spherical in shape with a mean circularity of 0.80 ± 0.13. The biosynthesized CuONPs showed concentration-dependent antifungal activity across the tested range (0.357-0.716 mg/ml), with the highest inhibition (100%) observed at 0.716 mg/mL against F. oxysporum f. sp. fragariae (Fof), 90.98% against F. oxysporum f. sp. mori (Fom), and 93.52% against F. oxysporum f. sp. lycopersici (Fol). These findings demonstrate that CuONPs biosynthesized using temperature-optimized T. harzianum supernatants act as a highly effective synergistic nanobiopesticide (achieving 90.98%-100% inhibition at 0.716 mg/mL) across multiple F. oxysporum formae speciales, serving as a novel and sustainable alternative to chemical fungicides.
Indexed as
Identifiers
42905240What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.